BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2315895)

  • 1. Platelet serotonergic mechanisms in ischaemic heart disease.
    Puri VK; Verma M; Saxena AK; Shanker K
    Thromb Res; 1990 Feb; 57(3):445-51. PubMed ID: 2315895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
    Gupta KK
    J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
    [No Abstract]   [Full Text] [Related]  

  • 4. CD40L activation in circulating platelets in patients with acute coronary syndrome.
    Lee Y; Lee WH; Lee SC; Ahn KJ; Choi YH; Park SW; Seo JD; Park JE
    Cardiology; 1999; 92(1):11-6. PubMed ID: 10640791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphinpyrazone and the platelet serotoninergic mechanism in ischaemic heart disease.
    Puri VK; Rawat A; Sharma A; Mehrotra A; Hasan M; Shanker K; Verma M; Sinha JN; Bhargava KP
    Br Med J (Clin Res Ed); 1986 Sep; 293(6547):591-3. PubMed ID: 3092937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet count and adherence to glass, in patients with (ischemic) coronary heart disease. II. Their detection in patients with myocardial infarct and intermediary syndromes].
    Babei E; Ungureanu E; Cristea E
    Stud Cercet Med Interna; 1973; 14(6):547-54. PubMed ID: 4766837
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo.
    Smitherman TC; Milam M; Woo J; Willerson JT; Frenkel EP
    Am J Cardiol; 1981 Sep; 48(3):395-402. PubMed ID: 6168192
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of platelet adhesiveness in myocardial infarction and ischaemic heart diseases.
    Shanker A; Gaur KJ; Ahmed KA; Laha NN
    Indian Heart J; 1978; 30(5):272-6. PubMed ID: 730207
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aggregation, reaction of serotonin liberation and electron microscopy of thrombocytes in ischemic heart disease].
    Liusov VA; Belousov IuB; Gracheva AI; Koroleva SA; To-Nam-Zen
    Kardiologiia; 1973 Dec; 13(12):32-7. PubMed ID: 4778834
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytes and coronary heart disease.
    Wilhelmsen L
    Circulation; 1991 Aug; 84(2):936-8. PubMed ID: 1860239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Number and glass adhesiveness of thrombocytes in patients with ischemic coronary cardiopathy. I. Their study on patients with painful ischemic cardiopathy (angina pectoris of effort), painless ischemic cardiopathy, or that associated with arterial hypertension].
    Babei E; Ungureanu E; Cristea E
    Stud Cercet Med Interna; 1970; 11(6):483-92. PubMed ID: 5510838
    [No Abstract]   [Full Text] [Related]  

  • 13. [Calcium metabolism of the thrombocytes in ischemic heart disease].
    Kiktev VG; Men'shikov MIu; Bugriĭ EM; Kuz'min AV; Karpov IuA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):58-61. PubMed ID: 3233156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W
    J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma heparin neutralizing activity in coronary artery disease.
    Dana B; Ellman L; Carvalho A; Daggett WM; Hutter AM
    Am J Cardiol; 1976 Jul; 38(1):9-11. PubMed ID: 937205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet cyclic GMP levels in unstable angina and myocardial infarction.
    Pistono M; Bergerone S; Carrieri L; Paglia I; Stefano D; Capizzi A; Ferri M; Pescarmona G; Bosia A; Trevi G
    Platelets; 2002; 13(5-6):307-11. PubMed ID: 12189017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemostasis in ischemic heart disease].
    Lukomskiĭ PE; Liusov VA; Belousov IuB
    Kardiologiia; 1971 Jan; 11(1):5-13. PubMed ID: 5574892
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet adhesiveness in ischaemic heart disease.
    Sharma SC; Balasubramanian V; Seth HN
    J Assoc Physicians India; 1977 Sep; 25(9):611-5. PubMed ID: 612658
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating platelet aggregate size in ischemic heart disease.
    Weinberger I; Fuchs J; Rotenberg Z; Almozlino A; Joshua H; Agmon J
    Angiology; 1986 Sep; 37(9):676-82. PubMed ID: 3767075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease.
    Serebruany VL; O'Connor CM; Gurbel PA
    Am J Cardiol; 2001 Jun; 87(12):1398-400. PubMed ID: 11397363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.